IRIS - Res&Arch Institutional Research Information System - Research & Archive

BARBATI, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.099
NA - Nord America 3.014
AS - Asia 1.979
AF - Africa 1.196
SA - Sud America 424
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 11.719
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.946
IT - Italia 2.795
MA - Marocco 1.149
SG - Singapore 887
UA - Ucraina 516
IE - Irlanda 378
RU - Federazione Russa 331
BR - Brasile 312
CN - Cina 309
SE - Svezia 264
HK - Hong Kong 263
DE - Germania 200
VN - Vietnam 199
FR - Francia 174
FI - Finlandia 153
GB - Regno Unito 93
NL - Olanda 52
IN - India 50
KR - Corea 48
AR - Argentina 39
BD - Bangladesh 37
MX - Messico 33
CH - Svizzera 32
TR - Turchia 32
PL - Polonia 25
IQ - Iraq 22
PE - Perù 21
ES - Italia 18
SA - Arabia Saudita 18
BE - Belgio 17
CA - Canada 17
JP - Giappone 15
PK - Pakistan 15
ZA - Sudafrica 15
AT - Austria 13
CO - Colombia 13
UZ - Uzbekistan 12
EC - Ecuador 11
PH - Filippine 11
CL - Cile 10
KE - Kenya 10
ID - Indonesia 9
GR - Grecia 8
LB - Libano 8
VE - Venezuela 8
MY - Malesia 7
RO - Romania 7
JO - Giordania 6
NP - Nepal 6
JM - Giamaica 5
GT - Guatemala 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
IL - Israele 3
LT - Lituania 3
LY - Libia 3
NG - Nigeria 3
PY - Paraguay 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AU - Australia 2
BY - Bielorussia 2
BZ - Belize 2
CY - Cipro 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
TH - Thailandia 2
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
IM - Isola di Man 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MD - Moldavia 1
MT - Malta 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
QA - Qatar 1
RE - Reunion 1
Totale 11.715
Salva come PNG Salva come JPEG
Città #
Ouezzane 1.142
Singapore 564
Chandler 415
Dublin 377
Hong Kong 263
San Mateo 256
Milan 195
Rome 184
San Jose 141
Boardman 137
Santa Clara 136
Ashburn 135
Des Moines 129
Moscow 112
Jacksonville 108
Dong Ket 105
Medford 105
Princeton 105
Ann Arbor 87
Lauterbourg 85
Naples 81
Wilmington 81
Beijing 66
Andover 62
Catania 56
Bologna 53
Bari 52
Seoul 45
Florence 44
Turin 44
Palermo 43
Helsinki 40
Perugia 40
New York 36
São Paulo 33
Ho Chi Minh City 32
Padova 25
Genoa 23
Saint Petersburg 23
Munich 22
Hanoi 20
Brescia 19
Altamura 18
Lima 18
Los Angeles 18
Piscataway 18
Redwood City 17
Woodbridge 17
Reggio Emilia 16
Dallas 15
Falkenstein 14
Frankfurt am Main 14
Lawrence 14
Norwalk 14
Shanghai 14
The Dalles 14
Dearborn 13
Pescara 13
San Francisco 13
Tokyo 13
Venice 13
Brussels 12
Baghdad 11
Falls Church 11
Jesi 11
London 11
Napoli 11
Orem 11
Pisa 11
Salerno 11
Izmir 10
Nairobi 10
Cagliari 9
Messina 9
Nuremberg 9
San Diego 9
Trieste 9
Warsaw 9
Brasília 8
Catanzaro 8
Chennai 8
Den Haag 8
Livorno 8
Monza 8
Turku 8
Auburn Hills 7
Buenos Aires 7
Chicago 7
Columbus 7
Dalmine 7
Jeddah 7
Manchester 7
Modena 7
Riyadh 7
Boston 6
Campinas 6
Chieti 6
Council Bluffs 6
Curitiba 6
Frankfurt Am Main 6
Totale 6.336
Salva come PNG Salva come JPEG
Nome #
Fisiopatologia del Cordone Ombelicale. 4.356
An immunoistochemical study of c-erbB-2 oncoprotein in breast cancer. 126
Renal Consequences of Gestational Diabetes Mellitus in Term Neonates: A Multidisciplinary Approach to the DOHaD Perspective in the Prevention and Early Recognition of Neonates of GDM Mothers at Risk of Hypertension and Chronic Renal Diseases in Later Life 124
Antigeni oncofetali in gravidanza. 123
Amniotic membrane: separation of amniotic mesoderm from amniotic epithelium and isolation of their respective mesenchymal stromal and epithelial cells. 119
Umbilical cord hematoma with altered fetal heart rate. A case report. 117
CA 125 and PLAP in maternal blood and amniotic fluid during pregnancy. 114
Liquido Amniotico: fisiologia e patologia 114
Cytotoxicity of universal dental adhesive systems: Assessment in vitro assays on human gingival fibroblasts 113
CA 125 in pregnancy 112
Biophysical and biochemical methods for early detection of breast tumours 111
Immunoblotting characterization of CA 125 in biological fluids:difference between pregnancy and cancer CA 125 origin. 109
Rare immunological presentation in B-cell chronic lymphocytic leukaemia. 106
Analisi dell'oncogene c-erbB-2 nell'adenocarcinoma gastrico mediante FISH. 104
Indagine sulle morti fetali endouterine: incidenza e cause riscontrate nel periodo 1994-2006 102
Immunochemical and immunohistochemical evaluation of lung permeability in ventilated newborn rabbits 102
Effect of aminophylline on lung maturation in preterm rabbit fetuses 102
Lung maturation and prematurity 99
Markers for breast cancer. 99
Biochemical parameters of renal impairment/injury and surrogate markers of nephron number in intrauterine growth-restricted and preterm neonates at 30–40 days of postnatal corrected age 99
A common aspect of pregnancy and malignancy: Oncofetal antigens. 97
CA 125 in human fluids:Facts and artifacts. 95
Analisi critica dei metodi per la valutazione della maturità polmonare fetale. 95
CA 125 in peritoneal fluid: Reliable values at high dilutions. 94
VALUATION OF BI OCHEMICAL PARAMETER S OF RENAL IMPAIRMENT/INJURY AND SURROGATE MARKER S OF NEPHRON NUMBER IN IUGR AND PRETERM NEONATES AT 30-40 DAYS OF POSTNATAL CORRECTED AGE 94
Increased urinary Cystatin-C levels correlate with reduced renal volumes in neonates with intrauterine growth restriction 89
Assessment of fetal lung maturity and prenatal prevention of respiratory distress syndrome. 85
Value of c-erbB-2 and p53 oncoprotein co-overexpression in human breast cancer. 84
The validation of immunoblot SDS-PAGE as a qualitative and quantitative method for the determination of urinary Cystatin C in neonates 84
Placental alkaline phosphatase as a marker for ovarian cancer. 83
Elevated peritoneal fluid levels of CA 125 in patients with endometriosis. 82
CA 125 and endometriosis 82
Biochemical markers of endometriosis 81
Antigeni oncofetali: loro possibili implicazioni in medicina fetale. 81
REDUCED RENAL VOLUMES AND ELEVATED LEVELS OF CYSTATIN-C IN THE URINE OF NEONATES WITH IUGR 81
Indagine sulla frequenza di infezioni da chlamydia in utenti consultoriali in Umbria. 79
Risk of breast cancer 77
Intrauterine fetal death incidence in the last ten years. 77
Tumor-associated trypsin inhibitor (TATI) in patients with ovarian carcinoma: comparison with CA 125. 75
Lysosomal glycohydrolases in patients with gynecological cancer. 75
Serum evaluation of p53 protein in gynecological cancer patients. 74
Fetal lung maturity: Diagnostic methods 73
Aspetti Immunologici della infertilità. Nota IV: ricerca degli anticorpi antispermatozoo mediante la tecnica dell'immunofluorescenza. 72
Evaluation of the second generation CA 125 assays 71
Hot-flashes in Breast Cancer Survivors: Effectiveness of Low-dosage Fluoxetine. A Pilot Study 71
The measurement of amniotic fluid phosphatidyl glycerol for the assessment of fetal lung maturity. 69
Incidenti del cordone ombelicale 68
Sviluppo e profilo biochimico del surfattante polmonare 68
Ontogeny of CA 125 antigen in pregnancy: Immunoradiometric determination in amniotic fluid and immunohistochemical localization in fetal membranes. 68
Bronchial washing as a model of R.D.S. in the adult. 68
Serum Evaluation of p53 Protein in Patients with Gnaecological Cancer. 67
Oncofetal antigens in pregnancy. 67
Identification of c-erbB-2 oncoprotein in serum: Elevated levels in breast cancer patients. 67
Regulation of CA125 Production by amnion cells in culture. 66
Regulation of CA 125 production by amnion and Wish cell in culture. 66
QF-PCR and MLPA: a reliable molecular system to detect chromosomal alterations in miscarriages 66
The trophoblast and monoclonal antibodies. 65
Analisi critica dei markers tumorali nella diagnosi del carcinoma ovarico. 65
Livelli di CA 125 nel siero e nel liquido peritoneale di pazienti con endometriosi. 65
No evidence of the hook effect in peritoneal fluid CA 125 measurement using immunoenzymatic second generation assays: comparison with immunoradiometric assays. 64
Main clinical analyses on amniotic fluid. 64
Monoclonal antibodies and the trophoblast. 64
Lung permeability of the immature and nearterm fetal rabbit: Immunochemical and immunohistochemical studies 64
Endocrinologia in Gravidanza. A) Modificazioni dell’assetto endocrino materno 64
Lo sviluppo morfologico del polmone fetale. 64
Hook effect in immunoradiometric assay for CA 125 determination in peritoneal fluid: Evidence of high CA 125 levels by a comparative immunoblotting analysis. 63
Serum and peritoneal fluid CA-125 levels in patients with endometriosis. 63
Biophysical and Biochemical Methods for early Detection of Breast Tumors. 63
Evidence of oncogene products in gynecological cancer patients 60
Serum quantification of HER-2/neu oncoprotein in gynecological patients. 60
HER-2 Amplification in Gastric Cancer Detected by Fluorescence in situ Hybridization. 60
Determination of CA 125 in peritoneal fluid: Reliable values at high dilutions. 59
Regulation of CA125 production by amnion and Wish cells in culture 59
Monoclonal antibodies and their application in gestational trophoblastic neoplasia 59
Marcatori tumorali umorali 58
Glucocorticoids and inositol interactions on fetal rabbit lung maturation. 56
The use of aminophylline for the treatment of preterm labor. 56
Effects of aminophylline on uterine activity 56
Placental alkaline phosphatase in ovarian and other tumours 56
Effect of aminophylline on lung maturation in preterm rabbit fetuses. 56
CA125 antigen levels in peritoneal fluid of gynecologic patients. 56
Screening ultrasonografico per la ricerca delle neoplasie ovariche ed endometriali in pazienti con età>45 anni: risultati preliminari 54
Studi sull'ontogenesi del marker oncofetale CA 125. 54
Immunohistochemical localization of CA 125 antigen in fetal membranes and placental tissue during gestation. 53
CA125 is released by human amnion cells in culture 53
La placenta e il liquido amniotico 52
Clinical value of serum c-erbB-2 vis-a-vis 3D echography in patients with breast cancer. 52
Inositol and glucocorticoid in the development of lung stability in male and female rabbit fetuses 50
Diagnosi e trattamento dell'immaturità polmonare. 50
Elevated erbB-2 oncoprotein levels in serum of patients with breast cancer. 49
Validità diagnostica dell'associazione di markers tumorali nel carcinoma ovarico. 49
Produzione di anticorpi monoclonali verso il sinciziotrofoblasto. 49
Fisiologia funzionale feto-placentare. 49
PLAP, TATI and CA 125 in ovarian cancer. 47
Valutazione del TATI come marker tumorale nella patologia oncologica. 46
p53 and HER-2 protein co-overexpression in human breast cancer 45
Clinical value of serum C-ERBB-2 vis-à-vis 3D echography in patients with breast tumor 45
Ruolo dei Marcatori Umorali nell'Endometriosi 44
Evaluation of IRMA-II and ETI-II assay in serum and peritoneal fluid CA 125 determination 43
Identificazione del marker tumorale CA 125 nel liquido seminale. 43
Totale 11.688
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.444
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022945 25 154 35 42 31 18 17 292 13 39 90 189
2022/20232.683 144 106 46 107 114 277 1.151 84 539 18 69 28
2023/2024809 57 77 37 56 47 21 101 49 65 67 104 128
2024/20252.047 78 205 190 104 183 110 97 185 351 142 290 112
2025/20262.592 196 167 133 370 349 224 310 146 333 233 73 58
2026/202725 25 0 0 0 0 0 0 0 0 0 0 0
Totale 11.885